BOT 2.41% 40.5¢ botanix pharmaceuticals ltd

Ann: Presentation- FDA Letter Requires Patient Instruction Update, page-52

  1. 2,097 Posts.
    lightbulb Created with Sketch. 575
    remember that the wording was already there on the bottle and on the carton.

    the NEW request from the fda was to "make it more prominent'.

    "prominent" is not something that is defined it is subjective.

    it is not in any information that can be looked up as it is the fda that stipulate based on its review of each product.

    this is in same regards to the decision around changing the formatting of the instructions again not something that was specified as a requirement before hand.

    remember the disappointment from management about it not being raised by the fda at prior feedback points.
    Last edited by FiSaver: 29/09/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
40.5¢
Change
-0.010(2.41%)
Mkt cap ! $734.6M
Open High Low Value Volume
42.0¢ 42.5¢ 39.5¢ $3.680M 8.989M

Buyers (Bids)

No. Vol. Price($)
18 297011 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 12027 3
View Market Depth
Last trade - 16.10pm 17/09/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.